Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism.
|
15844786 |
2005 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Incidentally simultaneous occurrence of RET/PTC, H4-PTEN and BRAF mutation in papillary thyroid carcinoma.
|
18226854 |
2008 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These targets include the proto-oncogenes BRAF and RET, known to be common mutations in thyroid cancer; vascular endothelial growth factor receptor and platelet-derived growth factor receptor, associated with angiogenesis; and the sodium-iodide symporter, with the aim of restoring its expression and hence radioactive iodine uptake.
|
20142332 |
2010 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.
|
18756447 |
2009 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.
|
14557473 |
2003 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients.
|
15741265 |
2005 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Three novel mutations in the RET proto-oncogene.
|
11692159 |
2001 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Exon 5 of the RET proto-oncogene: a newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg.
|
16419493 |
2005 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
|
9861322 |
1998 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation.
|
12193298 |
2002 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Thyroid cancer is frequently associated with the oncogenic conversion of the RET receptor tyrosine kinase.
|
16778204 |
2006 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.
|
17185892 |
2006 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
|
16483615 |
2006 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
BRAF(V600E) mutation analysis is superior to RAS point mutations and evaluation of RET/PTC rearrangements in the diagnosis of thyroid cancer, even in indeterminate lesions.
|
25333496 |
2015 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements.
|
17464312 |
2007 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Nevertheless, an extensive molecular analysis that included all codons was prompted by the diagnosis of thyroid neoplasm in a patient's sister, and identified the rare intracellular RET p.Ser891Ala mutation.
|
23295303 |
2012 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
These results suggest that, if the association between HT and thyroid cancer exists, its molecular basis is different from RET/PTC rearrangement.
|
11927965 |
2002 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Since fine-needle aspiration biopsy (FNAB) is an important component of the preoperative management of patients with thyroid tumors, we developed a rapid (20-min) method that enables extraction of DNA from FNABs for RET mutation analysis.
|
9824378 |
1998 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Rearrangements of the RET receptor tyrosine kinase gene generating RET/PTC oncogenes are specific to papillary thyroid carcinoma (PTC), the most frequent thyroid tumor.
|
16203990 |
2005 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Here we describe the first evidence of ret proto-oncogene rearrangement of thyroid cancer tissues around the site.
|
10551507 |
1999 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma.
|
18631007 |
2008 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A G691S RET polymorphism was present with a higher frequency in radiation-induced epithelial thyroid tumours (55%) than in sporadic tumours (20%) and in control normal thyroid tissues (15%).
|
12085189 |
2002 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The catalytic domain of RET can be used also for X-ray diffraction to obtain information about the three-dimensional structure, necessary for a rational design of selective inhibitors: it represents an important tool to understand the molecular mechanisms causing thyroid cancer and to care it.
|
16490247 |
2006 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
The RET IVS1-126G>T variant is strongly associated with the development of sporadic medullary thyroid cancer.
|
15142370 |
2004 |
Thyroid Neoplasm
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Germline RET proto-oncogene mutations are the genetic causes of multiple endocrine neoplasia type 2 and a strong genotype-phenotype correlation exists, particularly between a specific RET codon mutation and the (a) age-related onset and (b) thyroid tumor progression, from C-cell hyperplasia to medullary thyroid carcinoma and, ultimately, to nodal metastases.
|
22584703 |
2012 |